Dr Reddy’s makes three niche acquisitions in 30 days.

Last fortnight, when talk of a new india-specific fund being raised by Baring Private Equity Partners (India) surfaced, it brought into focus the firm’s success and the man largely responsible for it, Managing Partner Rahul Bhasin.

The most innovative companies don't do different things, they just do things differently. And that seems to make all the difference.

Barriers to innovation remain, but the most innovative companies have realised that \"innovation\" is not just about developing new products and services but, more fundamentally, about discovering new ways to create value. A Business Today-Monitor Group study profiles the most innovative Indian firms.

The Chairman of Dr Reddy’s Laboratories funds initiatives to alleviate hunger, create livelihoods, provide education and access to safe drinking water and pull back children from hazardous industries. So, how did the man who made his fortune in the ultra-competitive world of the global pharma business and whose first love is still science, morph into one of India’s largest givers? E. Kumar Sharma finds out.

When the drug molecule carrying his name let him down, Kallam Anji Reddy, the scientist Founder-Chairman of Dr Reddy’s Laboratories, hinged all his hopes on the Lord.

India’s handful of innovation-driven pharma companies are running through hundreds of crores of rupees in their endeavour to put a new drug on the global market. There have been a few setbacks along the way, but nobody’s giving up—not yet.

He wants to upend the governance system so that power returns to where it belongs: the people.

An out of court settlement reached between Ranbaxy Laboratories, Japan’s Astellas Pharma and Germany’s Boehringer Ingelhelm.

Citibank’s Suvidha, which was developed in India, is now being rolled out across the world. Other foreign banks are also taking innovative products developed here to other countries. Is India emerging as the global banking industry’s innovation factory?

Forayed: Into organised retail, the Mahindra Group’s fullyowned subsidiary, Mahindra Intertrade, under the brand name Mahindra Retail. It will roll out a chain of multi-format lifestyle stores across the country within the next year and operate in the premium lifestyle segment, selling international and private labels.

With the BSE sensex soaring past 17,000, the market is on a roll. Predicting where it will go seems to be futile as foreign inflows continue to prop up the stock market.

Listings are horribly hard to put together. This one is more so. For one, how does one measure power? For another, when there are so many talented and successful women in Indian business, how does one zero in on the 25 most powerful? The first question is relatively easy to answer.

The emergence of large retail chains has come as a boon for SMEs. They are freed from the hassles of marketing their products, and retailers get ready suppliers for a range of items.

Generic drugs will continue to dominate the Indian pharma market over the next five years, but multinational companies are lobbying to shape patent laws to protect their profitability over the long term. How far will they succeed?